Topical Treatment of Acute Otitis Media Through Tympanostomy Tubes (AOMT) and Its Effect on Microbial Flora
Completed
Conditions studied: Acute Otitis Media
In brief
The purpose of this observational study was to evaluate the effects of a topical fluoroquinolone (antibiotic) instilled into the otic (ear) canal to treat Acute Otitis Media through Tympanostomy Tubes (AOMT) on selected bacterial species on the skin near the ear, in the nose, and in the throat.
Key facts
- Study ID
- NCT01027494
- Run by
- Alcon Research
- People needed
- 318
- Starts
- 2009-12-01
- Expected to finish
- 2012-11-01
- Last updated by the study team
- 2013-03-18
Who can join
Age: 1 and older, up to 4. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Six months to less than 5 years of age at time of enrollment;
- Presence of bilateral, patent tympanostomy tubes;
- Otorrhea-free for at least 7 days following tympanostomy tube surgery (healthy group);
- Otorrhea up to and including 21 days in duration in at least one ear at Visit 1 (treatment group);
- Willing to refrain from significant water immersion of both ears without the use of adequate ear protection during swimming, bathing, showering and other water-related activities;
- Read and sign informed consent (parent or guardian);
- Other protocol-defined inclusion criteria may apply.
You may not qualify if…
- Ongoing/current therapy as described in protocol;
- Has received any treatment for current AOMT episode (treatment group);
- Otorrhea greater than 21 days in duration immediately prior to Day 1 visit (treatment group);
- History of or current acute or chronic non-tube otorrhea (through existing perforation of the eardrum);
- Current acute otitis externa (AOE), or malignant otitis externa (MOE) or other conditions which could interfere with evaluation of the study drug;
- Known or suspected ear infection of fungal or mycobacterial origin (treatment group);
- History or active herpes simplex, vaccina or varicella infections or overt viral infection of the tympanic membrane or the external canal;
- Prior otologic surgery, except that confined to the tympanic membrane, within one year of study entry;
- Diabetes;
- Any current known or suspected infection (other than AOMT) requiring systemic antimicrobial therapy;
- Known or suspected allergy or hypersensitivity to quinolones;
- Other protocol-defined exclusion criteria may apply.
Where it is running
- Contact Alcon Call Center for Trial Locations — Fort Worth, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.